Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

  • Technology appraisal guidance
  • TA223
  • Published: 

Do no do examples

Title Year published Impact Level
No results could be found